Why the study?
Bioprosthetic valve durability is limited by structural valve deterioration from calcification; this study evaluated intermediate-term clinical outcomes and hemodynamic performance of a novel RESILIA tissue designed to reduce calcification.
The novel RESILIA tissue bioprosthesis for surgical aortic valve replacement demonstrated excellent safety and hemodynamic performance with no structural valve deterioration at 4 years.
No takes yet. Share an insight, caveat, or question.
Early human data on RESILIA tissue are hypothesis-generating; leaves open durability questions pending randomized trials.
Bartuś et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: